CRISPR Therapeutics AG (CRSP)
60.14
+3.07
(+5.38%)
USD |
NASDAQ |
Aug 25, 12:27
CRISPR Therapeutics 1 Year Total Returns (Daily) : 5.07% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 5.07% |
| August 21, 2026 | 12.65% |
| August 20, 2026 | 9.52% |
| August 19, 2026 | 10.43% |
| August 18, 2026 | -8.02% |
| August 17, 2026 | -9.12% |
| August 14, 2026 | -8.96% |
| August 13, 2026 | -5.83% |
| August 12, 2026 | -4.61% |
| August 11, 2026 | -2.42% |
| August 10, 2026 | -2.71% |
| August 07, 2026 | -4.36% |
| August 06, 2026 | -8.34% |
| August 05, 2026 | -5.65% |
| August 04, 2026 | -10.94% |
| August 03, 2026 | -11.62% |
| July 31, 2026 | -14.70% |
| July 30, 2026 | -16.02% |
| July 29, 2026 | -19.28% |
| July 28, 2026 | -25.41% |
| July 27, 2026 | -27.84% |
| July 24, 2026 | -29.55% |
| July 23, 2026 | -30.25% |
| July 22, 2026 | -28.35% |
| July 21, 2026 | -26.30% |
| Date | Value |
|---|---|
| July 20, 2026 | -27.85% |
| July 17, 2026 | -13.27% |
| July 16, 2026 | -11.92% |
| July 15, 2026 | -2.58% |
| July 14, 2026 | -10.56% |
| July 13, 2026 | -10.86% |
| July 10, 2026 | -9.58% |
| July 09, 2026 | -6.22% |
| July 08, 2026 | 7.99% |
| July 07, 2026 | 18.71% |
| July 06, 2026 | 18.63% |
| July 02, 2026 | 16.28% |
| July 01, 2026 | 14.66% |
| June 30, 2026 | 12.13% |
| June 29, 2026 | 18.66% |
| June 26, 2026 | 17.60% |
| June 25, 2026 | 13.26% |
| June 24, 2026 | 14.47% |
| June 23, 2026 | 18.53% |
| June 22, 2026 | 22.85% |
| June 18, 2026 | 21.74% |
| June 17, 2026 | 22.92% |
| June 16, 2026 | 25.11% |
| June 15, 2026 | 27.20% |
| June 12, 2026 | 20.64% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Vertex Pharmaceuticals, Inc. | 38.59% |
| BeOne Medicines Ltd. | 18.59% |
| Basilea Pharmaceutica AG | 14.24% |
| Santhera Pharmaceuticals Holding AG | 26.36% |
| AC Immune SA | 33.02% |